Peter J. Van Veldhuizen
Metro Health Hospital(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer(2014)332 cited
- → Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline(2022)310 cited
- → Boron Chemicals in Diagnosis and Therapeutics(2013)272 cited
- → Retinoic acid signaling pathways in development and diseases(2013)265 cited
- → Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time(2013)247 cited
- → Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer(2010)213 cited
- → Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial(2013)159 cited
- → Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer(1993)133 cited
- → Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial(2022)130 cited
- → Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model(2009)122 cited